Among patients receiving radiation therapy (RT) for prostate cancer, intensity-modulated radiation therapy is significantly associated with a reduced risk for second primary solid malignancies compared with 3D conformal RT.
Investigators observed a complete response in more than half of patients treated with tislelizumab plus nab-paclitaxel for high-risk NMIBC that was not completely resectable.
Investigators sought to determine the efficacy and safety of N-803 plus BCG in patients with high-risk NMIBC.
Men undergoing radical cystectomy are most likely to recover erectile function if they have good function before the surgery and receive nerve-sparing, according to investigators.
Longer follow-up from the CheckMate 274 trial shows nivolumab given after radical surgery for high-risk muscle-invasive urothelial carcinoma maintains a clinically meaningful improvement in disease-free survival.
Low-burden, point-of-care program may increase access to and impact of treatment to assist tobacco cessation
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
In a Dutch study, each doubling of urine albumin excretion was significantly associated with a 7% increase in overall cancer risk.
Number of days alive and out of hospital within first 90 days greater for robot-assisted surgery, but clinical significance of findings unclear
A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.
